Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

NCT04018261 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

CMV Viremia
Immunosuppression-related Infectious Disease

Interventions

DRUG: Activated T-Lymphocytes

Sponsor

Banc de Sang i Teixits

Collaborators

[object Object]
[object Object]